Quantitative Systematic Strategies LLC Vericel Corp Transaction History

Quantitative Systematic Strategies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$30.93 - $59.48 $964,985 - $1.86 Million	-31,199 Reduced 81.85%	6,916 $384,000
Q4 2020 Feb 09, 2021	BUY	$18.53 - $31.5 $136,844 - $232,627	7,385 Added 24.03%	38,115 $1.18 Million
Q3 2020 Nov 09, 2020	BUY	$14.68 - $19.12 $451,116 - $587,557	30,730 New	30,730 $569,000
Q1 2019 Apr 15, 2019	SELL	$16.23 - $20.29 $197,486 - $246,888	-12,168 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$10.77 - $18.44 $131,049 - $224,377	12,168 New	12,168 $212,000
Q3 2018 Nov 14, 2018	SELL	$9.1 - $14.8 $101,346 - $164,827	-11,137 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$9.6 - $14.6 $106,915 - $162,600	11,137 New	11,137 $108,000

277

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.73B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.